MetroCity Bankshares, Inc. (MCBS) serves as the holding company for Metro City Bank, a Georgia-based bank established in 2006 and based in Doraville. It offers a variety of commercial banking services, such as checking and savings accounts, certificates of deposit (CDs), diverse loan options including commercial real estate and small business administration loans, treasury management, and online/mobile banking. In the regional banks space within financial services, MCBS targets underserved markets, especially immigrant and small business communities across the Southeast U.S.
From what I see, the company's approach centers on relationship banking, leveraging low-cost deposits and diversified lending to sustain a robust net interest margin (NIM). This strategy has enabled MCBS to hold steady through interest rate shifts, which accounts for its recent edge over broader bank indices via reliable profitability and solid capital levels.
In the past 30 days, MCBS shares moved up from a closing price of about $28.17 to around $31.14, delivering a +10.5% gain. The advance felt methodical, with the stock surpassing the 50-day moving average at $28.88, indicating growing momentum without sharp swings.
Looking at the quarter, the stock rose roughly +15.3% from about $27.01, demonstrating durability in a uneven environment for regional banks. It started range-bound but built steadily higher, backed by solid fundamentals and growing analyst focus.
A mix of company news and sector dynamics fueled MCBS's recent 30-day climb. On April 9, Keefe, Bruyette & Woods kept its Market Perform rating but lifted the price target from $32 to $33, showing faith in the bank's path and sparking buyer interest. This followed their March 23 adjustment from $31 to $32, which also lifted spirits.
One thing that stands out is the smooth leadership transition, with Farid Tan named Interim CFO on March 26 in what appeared to be standard changes, avoiding any disruption. Broader tailwinds like steadying interest rates and rising loan demand helped too, as regional players like MCBS gained from favorable inflation and jobs data.
I also checked this using Tickeron’s AI Screener to gauge how MCBS stacks up against peers in the sector.
The quarter's +15.3% rise rested on strong Q4 2025 results released January 30, featuring $18.3 million in net income and full-year revenue of $155.9 million, a 10.8% increase from the prior year. Even with a modest EPS shortfall ($0.68 against $0.73 expected), revenue topped forecasts, and a healthy NIM underscored efficiency.
A $0.25 per share quarterly cash dividend announced January 21 further supported investors, offering a yield of about 3.2%. Institutional ownership held firm, with short interest low at 1.4%. Positive industry shifts, like potential regulatory relief and Southeast growth, enhanced these strengths, offsetting prior book value strains from elevated rates.
In my trading routine, I often turn to Tickeron’s Trending AI Robots to spot top performers among hundreds of AI-driven bots scanning thousands of tickers. These bots apply strategies like trend-following, mean reversion, and momentum across short-term, swing, and long-term horizons. I appreciate the clear metrics on win rates, average returns, and Sharpe ratios, which help match bots to my approach. Updated live, the page flags recent standouts tied to market conditions. It's a practical way to add AI automation to my analysis and decisions—worth exploring if you're considering automated tools.
I'm watching the Q1 2026 earnings on April 17 closely, with expected EPS of $0.70-$0.77 and revenue near $50 million—pay particular attention to NIM and loan growth details. Fed rate moves and regional economic reports could shift views. Keep an eye on deposit growth and possible M&A too. On the risk side, watch credit quality or policy shifts, while upsides might come from more analyst notes or dividend tweaks. This is important because these elements could dictate MCBS's trajectory in the near term.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Be on the lookout for a price bounce soon.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MCBS advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 189 cases where MCBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MCBS moved out of overbought territory on April 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCBS as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MCBS turned negative on May 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MCBS broke above its upper Bollinger Band on April 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MCBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.634) is normal, around the industry mean (1.168). P/E Ratio (11.367) is within average values for comparable stocks, (17.089). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.320). Dividend Yield (0.033) settles around the average of (0.035) among similar stocks. P/S Ratio (5.040) is also within normal values, averaging (3.563).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company which engages in banking and financial solutions
Industry RegionalBanks